
Accelerating biologics development requires more than reducing timelines alone. Early-stage material generation must also deliver the scalability, consistency, and representative quality needed to support downstream development and manufacturing readiness.
Our latest whitepaper explores how Samsung Biologics’ integrated cell culture material generation strategy, aligned with cell line development (CLD), supports faster and more scalable biologics development workflows.
Key highlights include:
Reduced material delivery timelines from approximately 7.5 weeks to 5 weeks
More than 20× increase in material output compared to traditional workflows
Earlier access to high-quality, high-concentration material for ADC development
Improved ability to assess developability, formulation behavior, and conjugation suitability earlier in development
Discover how integrated material generation strategies can help reduce development complexity while improving scalability and process readiness across biologics development.

Accelerating biologics development requires more than reducing timelines alone. Early-stage material generation must also deliver the scalability, consistency, and representative quality needed to support downstream development and manufacturing readiness.
Our latest whitepaper explores how Samsung Biologics’ integrated cell culture material generation strategy, aligned with cell line development (CLD), supports faster and more scalable biologics development workflows.
Key highlights include:
Reduced material delivery timelines from approximately 7.5 weeks to 5 weeks
More than 20× increase in material output compared to traditional workflows
Earlier access to high-quality, high-concentration material for ADC development
Improved ability to assess developability, formulation behavior, and conjugation suitability earlier in development
Discover how integrated material generation strategies can help reduce development complexity while improving scalability and process readiness across biologics development.